Revising the hemodynamic criteria for pulmonary hypertension: A perspective from China-Reference-Cited by-同舟云学术

Revising the hemodynamic criteria for pulmonary hypertension: A perspective from China

Published:2023-03-01 Issue:1 Volume:11 Page:1-3
ISSN:2224-4018
Container-title:Journal of Translational Internal Medicine
language:en
Short-container-title:

Author:

Xiong Changming¹,Yang Beilan¹

Affiliation:

1. Center of Pulmonary Vascular Disease, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing , China

Publisher

Walter de Gruyter GmbH

Subject

Internal Medicine

Link

https://www.degruyter.com/document/doi/10.2478/jtim-2022-0023/pdf

Reference16 articles.

1. Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 2019;53:1801913.

2. Liu J, Yang P, Tian H, Zhen K, McCabe C, Zhao L, et al. Right ventricle remodeling in chronic thromboembolic pulmonary hypertension. J Transl Intern Med 2022;10:125–33.

3. Chronic cor pulmonale. Report of an expert committee. World Health Organ Tech Rep Ser 1961;213:35.

4. Mao J, Sun R. Normal pressure curve and its calculation formula, cardiac catheterization and diagnosis. 1st ed. Changchun: Jilin People’s Press, 1979.

5. Kovacs G, Berghold A, Scheidl S, Olschewski H. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J 2009;34:888-94.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2023 Guideline for the management of hypertension in the elderly population in China;Journal of Geriatric Cardiology;2024-06

2. The impact of female sex hormones on cardiovascular disease: from mechanisms to hormone therapy;Journal of Geriatric Cardiology;2024-06

3. Serum ASGR2 level: an efficacy biomarker for balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension;Frontiers in Immunology;2024-05-24

4. Medical Management of Pulmonary Arterial Hypertension: Current Approaches and Investigational Drugs;Pharmaceutics;2023-05-24